Lyra Therapeutics Inc (NASDAQ:LYRA)
| 2.12 BATS BZX Real-Time Price As of Mar 27 |  0.00 / 0.00%Today’s Change | 1.86 Today|||52-Week Range 8.18 | -32.48% Year-to-Date |
Latest LYRA News | Press Releases
No recent news for Lyra Therapeutics Inc.
Today’s Trading
| Previous close | 2.12 |
| Today’s open | 1.91 |
| Day’s range | 1.91 - 2.12 |
| Volume | 782 |
| Average volume (3 months) | 32,528 |
| Market cap | $61.5M |
Data as of 3:59pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | -29.41% |
| Earnings growth (this year) | +46.85% |
| Earnings growth (next 5 years) | +41.73% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 198.67 |
| Price/Book | 0.73 |
Competitors
| No competitors data available. |
Financials
| Last reporting date | March 28, 2023 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $285.0K |
| Annual profit (last year) | -$43.5M |
| Net profit margin | -15,267.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
